In terms of Regulation 30(4) of SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and reference to letter dated November 14, 2023 and December 26, 2023 regarding a material litigation filed by Northern TK Venture, the Promoter shareholder of the Company (NTK), against Daiichi Sankyo Company, before the Tokyo District Court in Japan, Fortis Healthcare has informed that a copy of the announcement released by IHH Parent Company of NTK, to the Bursa, Malaysia and Singapore Stock Exchanges is enclosed. They will inform in case of any material developments on the above matter.
The above information is a part of company’s filings submitted to BSE.